NAMS
NewAmsterdam Pharma Company NV

417
Loading...
Loading...
News
all
press releases
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Tops Revenue Estimates
NewAmsterdam Pharma Company N.V. (NAMS) delivered earnings and revenue surprises of +71.15% and +486.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Citi initiates coverage on biotech amid improving sentiment in sector
Investing.com -- Citi initiated coverage on small- and mid-cap biotechnology companies on early signs of improving sentiment in a sector weighed down this year by policy uncertainty and weak investor interest.
investing.com·3mo ago
News Placeholder
NewAmsterdam Pharma Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
read more...
Benzinga·10mo ago
News Placeholder
What 4 Analyst Ratings Have To Say About NewAmsterdam Pharma
read more...
Benzinga·10mo ago
News Placeholder
TD Cowen Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on NewAmsterdam Pharma Company (NAMS Research Report). The comp...
TipRanks Financial Blog·1y ago
News Placeholder
Analyst Confident In NewAmsterdam Pharma's Cholesterol Drug Despite Mixed Reactions To Study Results
NewAmsterdam Pharma announced positive topline results from the Phase 3 BROOKLYN trial for obicetrapib, showing a significant LDL-C reduction in HeFH patients. The stock fell 8.35% despite the...
Benzinga·1y ago
News Placeholder
RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)
RBC Capital analyst Leonid Timashev maintained a Buy rating on NewAmsterdam Pharma Company (NAMS Research Report) yesterday and set a price targe...
TipRanks Financial Blog·1y ago
News Placeholder
Piper Sandler Sticks to Its Buy Rating for NewAmsterdam Pharma Company (NAMS)
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on NewAmsterdam Pharma Company (NAMS Research Report) today and set a price target o...
TipRanks Financial Blog·1y ago
News Placeholder
NewAmsterdam Pharma Announces Executive Leadership Changes
An announcement from NewAmsterdam Pharma Company (NAMS) is now available. NewAmsterdam Pharma Company N.V. has announced Juliette Audet's new role...
TipRanks Financial Blog·1y ago
News Placeholder
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
NAARDEN, the Netherlands and MIAMI, April 01, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or NewAmsterdam or the Company ), a late-stage, clinical biopharmaceutical...
Globe Newswire·1y ago

Latest NAMS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.